Compare TVGN & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVGN | GPMT |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Real Estate Investment Trusts |
| Sector | Finance | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3M | 24.5M |
| IPO Year | 2021 | 2017 |
| Metric | TVGN | GPMT |
|---|---|---|
| Price | $6.10 | $2.08 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.38 |
| AVG Volume (30 Days) | 7.8K | ★ 33.5K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 17.70% |
| EPS Growth | N/A | ★ 73.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $144.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.74 |
| 52 Week High | $24.91 | $7.61 |
| Indicator | TVGN | GPMT |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 28.40 |
| Support Level | $5.01 | $1.31 |
| Resistance Level | $7.22 | $7.61 |
| Average True Range (ATR) | 0.42 | 0.30 |
| MACD | 0.08 | -0.21 |
| Stochastic Oscillator | 53.23 | 0.57 |
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.